Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences — Neutral

APLS   GlobeNewsWire — August 27, 2025

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences:

image for news Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences — Neutral

FHTX   GlobeNewsWire — August 27, 2025

CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in Citi's 2025 Biopharma Back to School Summit, 2025 Wells Fargo Healthcare Conference, and Morgan Stanley 23rd Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn's Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.

image for news Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright Global Investment Conference in New York City and will present a company overview at 3:00 p.m. ET on September 8, 2025.

image for news Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Avalo Therapeutics to Participate in Upcoming Investor Conferences — Neutral

AVTX   GlobeNewsWire — August 27, 2025

WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:

image for news Avalo Therapeutics to Participate in Upcoming Investor Conferences

TORONTO--(BUSINESS WIRE)--Bench IQ, the AI-powered judicial intelligence platform used by the world's top law firms, today announced it has raised a $5.3 million seed round led by Battery Ventures and Inovia Capital, with participation from CIBC Innovation Banking, MVP Ventures, Maple VC and Haystack VC. The new funding will fuel Bench IQ's growth, with a focus on expanding its proprietary dataset, advancing its AI agents, and expanding the team in the U.S. and Canada. Leading AmLaw 200 law fir.

image for news Bench IQ Raises $5.3 Million Seed Round to Arm Litigators with AI-Driven Intel on Judges

ANCHORAGE, Alaska , Aug. 27, 2025 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce that it is well underway with exploration at its 100% owned Whistler Gold-Copper Project (the "Whistler Project" or "Project") for the 2025 field season in Alaska. The program is focused on targeting continued growth through developing new drill targets at the Whistler Orbit and Muddy Creek prospect areas.

image for news U.S. GoldMining Advances 2025 Exploration Program Targeting Continued Growth at the District Scale Whistler Gold-Copper Project, Alaska

BlackBerry Appoints Barry Mainz to its Board of Directors — Neutral

BB   Accesswire — August 27, 2025

WATERLOO, ONTARIO / ACCESS Newswire / August 27, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) announced today that it has appointed software executive Barry Mainz to its Board of Directors. Mr. Mainz is a technology veteran with 30 years of experience in executive leadership, global sales, marketing, product-led growth, and product development.

image for news BlackBerry Appoints Barry Mainz to its Board of Directors

BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--HERTHENA-Breast04 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic HR+/HER2- Breast Cancer.

image for news HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP).

image for news Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)

RALEIGH, N.C.--(BUSINESS WIRE)--Driivz, a Vontier (NYSE: VNT) company and leading global software supplier to EV charging operators and service providers, today announced a partnership with ENAPI, a Berlin-based roaming connectivity platform, to deliver seamless, scalable EV charging across borders and networks, benefitting charge point operators (CPOs), e-mobility service providers (eMSPs), and EV drivers alike. This partnership unites the Driivz Smart EV Charging and Energy Management platfor.

image for news Vontier's Driivz Partners With ENAPI to Expand Global EV Roaming and Simplify Connectivity

The J.M. Smucker Co. Announces Fiscal 2026 First Quarter Results — Neutral

SJM   PRNewsWire — August 27, 2025

ORRVILLE, Ohio , Aug. 27, 2025 /PRNewswire/ -- The J.M. Smucker Co. (NYSE: SJM) today announced results for the first quarter ended July 31, 2025, of its 2026 fiscal year.

image for news The J.M. Smucker Co. Announces Fiscal 2026 First Quarter Results

Bio-Techne to Present at Upcoming Investor Conferences — Neutral

TECH   PRNewsWire — August 27, 2025

MINNEAPOLIS , Aug. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 2025 Wells Fargo Healthcare Conference September 3, 2025 10:15 AM EDT Baird 2025 Global Healthcare Conference September 9, 2025 9:05 AM EDT Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:45 AM EDT A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and …

image for news Bio-Techne to Present at Upcoming Investor Conferences

MPLX LP to Divest Rockies Gathering and Processing Assets — Neutral

MPLX   PRNewsWire — August 27, 2025

FINDLAY, Ohio , Aug. 27, 2025 /PRNewswire/ -- MPLX LP (NYSE: MPLX) today announced it has entered into a definitive agreement to divest its Rockies gathering and processing assets to a subsidiary of Harvest Midstream for $1.0 billion in cash consideration, subject to customary purchase price adjustments. Harvest has contractually agreed to dedicate approximately 12 thousand barrels per day of NGLs from these assets to MPLX for a period of seven years commencing in 2028, following the expiration of a pre-existing commitment.

image for news MPLX LP to Divest Rockies Gathering and Processing Assets

SHANGHAI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ECARX (Nasdaq: ECX), a global mobility technology provider, today announced that its Antora® 1000 Pro computing platform has received Automotive SPICE (ASPICE) v4.0 Capability Level 3 (CL3) certification – the highest rating under the ASPICE standard. This adds to ECARX's growing portfolio of certifications - prerequisites for collaboration with leading automakers – and underscores its commitment to building a robust, fully compliant infrastructure as the foundation for its accelerated global expansion and continued innovation.

image for news ECARX Receives ASPICE v4.0 CL3 Certification, Reinforcing Global Expansion and Technology Leadership

BXCL501 achieved SERENITY At-Home's primary endpoint of being well tolerated in the at-home treatment of agitation episodes in patients with bipolar disorders or schizophrenia

image for news BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware, and services, today announced that it has entered into a definitive agreement with GENDA Inc. (“GENDA,” TSE:9166), a global entertainment company, relating to the sale of Inspired's UK holiday parks business and certain associated leisure assets (“Indigo NewCo Limited”) for total consideration of approximately £18.6 million ($25.1 million1) in cash, subject to customary adjustments and closing conditions. In addition, Inspired will provide gaming content and platform services on a recurring revenue basis to Indigo …

image for news Inspired Announces Proposed Sale of UK Holiday Parks Business to GENDA Inc.

Virtual KOL event will begin at 8:00 AM ET on Thursday, September 4, 2025 Virtual KOL event will begin at 8:00 AM ET on Thursday, September 4, 2025

image for news Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond™ Phase 2a Topline Clinical Data Readout

REHOVOT, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced that the Company's CEO, Gil Efron will participate in a fireside chat and 1x1 investor meeting at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8-10, 2025.

image for news Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

CTW to Participate in the Lake Street 2025 BIG9 Conference — Neutral

CTW   GlobeNewsWire — August 27, 2025

TOKYO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) (“CTW” or “the Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, which showcases a diverse selection of free-to-play games inspired by popular Japanese animations, announced today that management will participate in the Lake Street Capital Markets Best Ideas Growth (BIG9) Conference taking place in New York City on September 11, 2025. Management will conduct one-on-one meetings throughout the day.

image for news CTW to Participate in the Lake Street 2025 BIG9 Conference

SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak (NYSE:TRAK), the world's largest food traceability and regulatory compliance network, leveraging its established inventory management and out-of-stock reduction SaaS platform, is proud to announce the addition of 28 deli, cheese and antipasti suppliers to the queue joining the ReposiTrak Traceability Network® (RTN). These companies will efficiently exchange intricate, FDA-required Key Data Elements (KDEs) for each Critical Tracking Event (CTE) in thei.

image for news 28 Deli, Cheese and Antipasti Suppliers Join the ReposiTrak Queue for Food Traceability That Meets the Requirements of Multiple Wholesale Customers